Search

Your search keyword '"Bateman, Nicholas W."' showing total 287 results

Search Constraints

Start Over You searched for: Author "Bateman, Nicholas W." Remove constraint Author: "Bateman, Nicholas W."
287 results on '"Bateman, Nicholas W."'

Search Results

1. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors

3. Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities

5. Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities

6. Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling

7. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors

8. Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes

9. Deep learning-based segmentation of multisite disease in ovarian cancer

11. In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy

14. Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

15. ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data

16. Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry

17. Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer

18. Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment

19. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

20. Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities

21. Multi-omic Analysis of Uterine Leiomyomas in Self-Described Black and White Women: Molecular Insights into Health Disparities

22. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

24. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

25. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States

26. Microenvironment Shapes Cell State, Plasticity, and Heterogeneity of Small Cell Lung Cancer

27. Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens

28. Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer

30. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients

31. Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis

32. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer ® -Accredited Facilities in the United States.

35. ProteoMixture: A Cell Type Deconvolution Tool for Bulk Tissue Proteomics Data

36. Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer

37. Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies

38. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer

39. Abstract 5782: The dynamic immune behavior of primary and metastatic tumors of ovarian cancer

40. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer

41. Deep learning-based Segmentation of Multi-site Disease in Ovarian Cancer

43. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

44. Additional file 1 of Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

46. Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics

47. Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study

50. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning

Catalog

Books, media, physical & digital resources